Moesin-induced adriamycin resistance through IL-6/MSN/STAT3 axis and therapeutic efficacy of atovaquone in chemotherapy resistant triple-negative breast cancer

被引:0
|
作者
Lee, Cheng Hyun
Kim, Da Sol
Park, Soo Young
Ryu, Han Suk
机构
关键词
D O I
10.1158/1538-7445.AM2023-2774
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2774
引用
收藏
页数:2
相关论文
共 50 条
  • [41] DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients
    Vasiyani, Hitesh
    Mane, Minal
    Rana, Khushboo
    Shinde, Anjali
    Roy, Milton
    Singh, Jyoti
    Gohel, Dhruv
    Currim, Fatema
    Srivastava, Ratika
    Singh, Rajesh
    APOPTOSIS, 2022, 27 (11-12) : 961 - 978
  • [42] The IL-6/sTaT3 Signaling Pathway Is An Early Target of Manuka Honey-Induced Suppression of Human Breast Cancer Cells
    Aryappalli, Priyanka
    Al-Qubaisi, Sarah S.
    Attoub, Samir
    George, Junu A.
    Arafat, Kholoud
    Ramadi, Khalil B.
    Mohamed, Yassir A.
    Al-Dhaheri, Mezoon M.
    Al-Sbiei, Ashraf
    Fernandez-Cabezudo, Maria J.
    al-Ramadi, Basel K.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [43] DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients
    Hitesh Vasiyani
    Minal Mane
    Khushboo Rana
    Anjali Shinde
    Milton Roy
    Jyoti Singh
    Dhruv Gohel
    Fatema Currim
    Ratika Srivastava
    Rajesh Singh
    Apoptosis, 2022, 27 : 961 - 978
  • [44] STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
    Kuo, Wei-Ying
    Hwu, Luen
    Wu, Chun-Yi
    Lee, Jhih-Shian
    Chang, Chi-Wei
    Liu, Ren-Shyan
    THERANOSTICS, 2017, 7 (03): : 647 - 663
  • [45] Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
    Ibrahim, Sherif Abdelaziz
    Gadalla, Ramy
    El-Ghonaimy, Eslam A.
    Samir, Omnia
    Mohamed, Hossam Taha
    Hassan, Hebatallah
    Greve, Burkhard
    El-Shinawi, Mohamed
    Mohamed, Mona Mostafa
    Goette, Martin
    MOLECULAR CANCER, 2017, 16
  • [46] Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
    Sherif Abdelaziz Ibrahim
    Ramy Gadalla
    Eslam A. El-Ghonaimy
    Omnia Samir
    Hossam Taha Mohamed
    Hebatallah Hassan
    Burkhard Greve
    Mohamed El-Shinawi
    Mona Mostafa Mohamed
    Martin Götte
    Molecular Cancer, 16
  • [47] SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways
    Acevedo-Diaz, Ariana
    Morales-Caban, Beatriz M.
    Zayas-Santiago, Astrid
    Martinez-Montemayor, Michelle M.
    Suarez-Arroyo, Ivette J.
    CANCERS, 2022, 14 (11)
  • [48] RETRACTED: IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells (Retracted Article)
    Li, Yu
    Chen, Gang
    Han, Zhijian
    Cheng, Huijuan
    Qiao, Liang
    Li, Yumin
    ONCOTARGETS AND THERAPY, 2020, 13 : 9721 - 9730
  • [49] Icariside I reduces breast cancer proliferation, apoptosis, invasion, and metastasis probably through inhibiting IL-6/STAT3 signaling pathway
    Hou, Manting
    Li, Hui
    He, Tingting
    Hui, Siwen
    Dai, Wenzhang
    Hou, Xiaorong
    Zhao, Jing
    Zhao, Jia
    Wen, Jincai
    Kan, Wen
    Xiao, Xiaohe
    Zhan, Xiaoyan
    Bai, Zhaofang
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024, 76 (05) : 499 - 513
  • [50] Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
    Ibrahim, Sherif A.
    Hassan, Hebatallah
    Vilardo, Laura
    Kumar, Sampath Katakam
    Kumar, Archana Vijaya
    Kelsch, Reinhard
    Schneider, Cornelia
    Kiesel, Ludwig
    Eich, Hans Theodor
    Zucchi, Ileana
    Reinbold, Rolland
    Greve, Burkhard
    Goette, Martin
    PLOS ONE, 2013, 8 (12):